News

Filter

Current filters:

DiovanGlobal

Fixed-dose antihypertensive cannot stem tide of patent expiries

04-09-2009

Following the patent expiries of angiotensin II receptor blockers (ARBs), Datamonitor expects antihypertensives…

Aliskiren TabletsAmlodipine and ValsartanCardio-vascularCozaarDiovanExforgeGenericsGlobalLosartan PotassiumNovartisPharmaceuticalTekturnavalsartan

COMPANY SPOTLIGHT

Menarini

Back to top